{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:50:00Z","timestamp":1794963000101,"version":"4.9.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008871","name":"Yunnan Province Science and Technology Department","doi-asserted-by":"crossref","award":["202201AY070001-294"],"award-info":[{"award-number":["202201AY070001-294"]}],"id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Cefotaxime is a widely used 3rd-generation cephalosporin antibiotic that is primarily excreted through urine. Third-generation cephalosporins (e.g., ceftazidime, ceftriaxone) and the 4th-generation cefepime are associated with neurological complications. Although cephalosporin-associated encephalopathy (CAE) is well-documented, cases specifically induced by cefotaxime remain remarkably rare. To our knowledge, this is the 1st documented case of cefotaxime-induced CAE in a patient undergoing peritoneal dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 72-year-old female patient on peritoneal dialysis developed delirium and impaired consciousness 7 days after receiving cefotaxime as part of her anti-infective therapy for a pulmonary infection. The patient expressed concern regarding the onset of impaired consciousness and intermittent delirium as well as her prognosis and potential sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>This investigation focused on the potential role of cefotaxime in triggering CAE in peritoneal dialysis patients. The likelihood of cefotaxime causing drug reactions was confirmed using the Naranjo Scale score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Following the suspicion of cefotaxime-induced encephalopathy, the treatment regimen was modified, which included discontinuation of cefotaxime, initiation of intravenous piperacillin\/bactam as an alternative antibiotic therapy, and symptomatic treatment with olanzapine. Close monitoring and adjustments to the peritoneal dialysis regimen are essential for managing neurological symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>After discontinuation of cefotaxime and appropriate adjustments to the treatment regimen, the patient\u2019s clinical condition gradually improved. Symptoms of delirium subsided, consciousness returned to normal, and laboratory indicators stabilized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case emphasizes the importance of considering the potential adverse effects of antibiotics, particularly in patients with kidney insufficiency undergoing dialysis. This highlights the necessity of vigilance in monitoring drug-related complications for timely detection of encephalopathic symptoms and development of individualized treatment strategies. We acknowledge that cefotaxime may increase the risk of CAE in patients on peritoneal dialysis, necessitating heightened awareness among physicians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000042915","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T17:00:29Z","timestamp":1750698029000},"page":"e42915","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cefotaxime-associated encephalopathy in peritoneal dialysis patients: A case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Gao","family":"Song","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Puer People\u2019s Hospital, Pu\u2019er, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Puer People\u2019s Hospital, Pu\u2019er, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ning\u2019er County Hospital of Traditional Chinese Medicine, Pu\u2019er, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Qun","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Puer People\u2019s Hospital, Pu\u2019er, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5871-4681","authenticated-orcid":false,"given":"Cai-Qiong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Puer People\u2019s Hospital, Pu\u2019er, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260613","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3389\/fphar.2020.01033","article-title":"Tolerability, safety, pharmacokinetics and drug interaction of cefotaxime sodium-tazobactam sodium injection (6:1) following single and multiple intravenous doses in Chinese healthy subjects.","volume":"11","author":"Chen","year":"2020","journal-title":"Front Pharmacol"},{"key":"R2-20260613","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijid.2021.01.025","article-title":"No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: a pilot study.","volume":"104","author":"Pilmis","year":"2021","journal-title":"Int J Infect Dis"},{"key":"R3-20260613","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1093\/jac\/dkac334","article-title":"Target attainment and pharmacokinetics of cefotaxime in critically ill patients undergoing continuous kidney replacement therapy.","volume":"77","author":"Wieringa","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"R4-20260613","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/clpt.1985.172","article-title":"Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.","volume":"38","author":"Albin","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"R5-20260613","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1212\/01.wnl.0000499649.36058.c0","article-title":"Antibiotic-associated encephalopathy.","volume":"87","author":"Stip","year":"2016","journal-title":"Neurology"},{"key":"R6-20260613","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40264-017-0578-2","article-title":"Neurological adverse effects attributable to \u03b2-lactam antibiotics: a literature review.","volume":"40","author":"Deshayes","year":"2017","journal-title":"Drug Saf"},{"key":"R7-20260613","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/cid\/ciz857","article-title":"Ceftaroline-associated encephalopathy in patients with severe kidney impairment.","volume":"70","author":"Martin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R8-20260613","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review.","volume":"21","author":"Payne","year":"2017","journal-title":"Crit Care"},{"key":"R9-20260613","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2022.01.023","article-title":"Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid.","volume":"116","author":"Nishioka","year":"2022","journal-title":"Int J Infect Dis"},{"key":"R10-20260613","first-page":"92","article-title":"Cefotaxime-induced encephalopathy in an uremic patient.","volume":"54","author":"Pascual","year":"1990","journal-title":"Nephron"},{"key":"R11-20260613","first-page":"322","article-title":"Encephalopathy caused by Cefotaxime. A case in an aged patient with renal failure.","volume":"140","author":"Vincent","year":"1989","journal-title":"Ann Med Interne (Paris)"},{"key":"R12-20260613","first-page":"2370","article-title":"An unusual case of a side effect. Cefotaxime-induced confusion in a patient with kidney failure.","volume":"100","author":"Brink","year":"2003","journal-title":"Lakartidningen"},{"key":"R14-20260613","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.clinthera.2014.09.020","article-title":"Neurotoxicity with antimicrobials in the elderly: a review.","volume":"36","author":"Mattappalil","year":"2014","journal-title":"Clin Ther"},{"key":"R15-20260613","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1001\/jama.291.14.1753","article-title":"Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit.","volume":"291","author":"Ely","year":"2004","journal-title":"JAMA"},{"key":"R16-20260613","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/cc6149","article-title":"Delirium in the intensive care unit.","volume":"12","author":"Girard","year":"2008","journal-title":"Crit Care"},{"key":"R17-20260613","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/archinte.165.14.1657","article-title":"Premature death associated with delirium at 1-year follow-up.","volume":"165","author":"Leslie","year":"2005","journal-title":"Arch Intern Med"},{"key":"R18-20260613","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199903043400901","article-title":"A multicomponent intervention to prevent delirium in hospitalized older patients.","volume":"340","author":"Inouye","year":"1999","journal-title":"N Engl J Med"},{"key":"R19-20260613","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(11)61253-1","article-title":"Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.","volume":"378","author":"Greinacher","year":"2011","journal-title":"Lancet"},{"key":"R20-20260613","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10157-008-0115-9","article-title":"Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with kidney failure.","volume":"13","author":"Ozturk","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"R21-20260613","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0883073807304016","article-title":"Aseptic meningitis associated with cephalosporins in an infant with trisomy 21.","volume":"22","author":"Nakajima","year":"2007","journal-title":"J Child Neurol"},{"key":"R22-20260613","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)00767-7","article-title":"Nonconvulsive status epilepticus associated with cephalosporins in patients with kidney failure.","volume":"111","author":"Mart\u00ednez-Rodr\u00edguez","year":"2001","journal-title":"Am J Med"},{"key":"R23-20260613","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0253-7613.91884","article-title":"Ceftriaxone-induced acute reversible encephalopathy in a patient with enteric fever.","volume":"44","author":"Sharma","year":"2012","journal-title":"Indian J Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T13:00:31Z","timestamp":1781355631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":22,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042915","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}